Moreover, Kaplan–Meier analysis of data from the TCGA database indicated that patients with GC with higher FERMT1 mRNA levels have lower overall survival (OS) (Figure 2a), FP (Figure 2b) and PPS (Figure 2c) than those with lower levels of FERMT1. The gene discussed is FERMT1; the disease is gastric cancer.